Using a different radionuclide and vector, Chen et al. demonstrated that 177Lu bound to the αvβ3 integrin-targeting peptide Arg-Gly-Asp (177Lu-RGD) improved tumor control and increased overall survival in mice bearing MC38 colon cancer tumors when combined with anti-PD-L1 [56]. This evidence concerns the gene CD274 and neoplasm.